Real-World Dosing Patterns and Outcomes Among Patients With Chronic Lymphocytic Leukemia With or Without Dose Adjustment of First-Line Ibrutinib

被引：0
|
作者：
Rogers, Kerry [1 ]
Lu, Xiaoxiao [2 ]
Emond, Bruno [3 ]
Ding, Zhijie [2 ]
Lefebvre, Patrick [3 ]
Lafeuille, Marie-Helene [3 ]
Mavani, Heena [2 ]
Qureshi, Zaina [2 ]
Ghosh, Nilanjan [4 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Janssen Sci Affairs, Horsham, PA USA
[3] Anal Grp Inc, Montreal, PQ, Canada
[4] Levine Canc Inst, Charlotte, NC USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
CLL; dose adjustment; real-world dosing; ibrutinib; chronic lymphocytic leukemia; outcomes;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-586
引用
下载
收藏
页码：S330 / S330
页数：1
相关论文
共 50 条
  • [41] Real-World First-Line Treatment Patterns Among US Carcinoid Syndrome Patients
    Sun, Gordon H.
    Neary, Maureen P.
    Chang, Eunice
    Broder, Michael S.
    PANCREAS, 2015, 44 (02) : 359 - 360
  • [42] Real-World Outcomes Among 2L+Patients with Chronic Lymphocytic Leukemia (CLL) By Line of Therapy (LOT)
    Davids, Matthew S.
    Ambrose, Jacob
    De Nigris, Enrico
    Prescott, Jennifer
    Leng, Siyang
    Farooqui, Mohammed Z. H.
    Gandra, Shravanthi R.
    Zettler, Christina M.
    Fernandes, Laura L.
    Wang, Ching-Kun
    Shadman, Mazyar
    BLOOD, 2023, 142
  • [43] Time to next treatment in patients with chronic lymphocytic leukemia initiating first-line ibrutinib or acalabrutinib
    Jacobs, Ryan
    Lu, Xiaoxiao
    Emond, Bruno
    Morrison, Laura
    Kinkead, Frederic
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Khan, Wasiulla
    Wu, Linda H.
    Qureshi, Zaina P.
    Levy, Moshe Yair
    FUTURE ONCOLOGY, 2024, 20 (01) : 39 - 53
  • [44] Real-World Treatment Patterns and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib in the UK: A Preliminary Analysis
    Xie, Jing
    Yong, Alan
    Waweru, Catherine
    Sorof, Thuy Anh
    Goyal, Ravi K.
    Davis, Keith L.
    Follows, George
    Hillmen, Peter
    BLOOD, 2019, 134
  • [45] Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia in China: A Retrospective Analysis Using a Real-World Database
    Liu, Yin
    Chen, Yanfei
    Xiao, Yue
    Huang, Ruijian
    Jiang, Feng
    Yi, Shuhua
    Zhou, Jifang
    BLOOD, 2023, 142
  • [46] Real-world clinical outcomes in patients receiving either ibrutinib or chemoimmunotherapy (CIT) as first-line (1L) treatment for chronic lymphocytic leukemia (CLL) / small lymphocytic lymphoma (SLL): A retrospective analysis.
    Wu, Linda
    Ran, Tao
    He, Jinghua
    Panjabi, Sumeet
    Lu, Xiaoxiao
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study
    Tsuyoshi Muta
    Yosuke Masamoto
    Go Yamamoto
    Shingo Kurahashi
    Yoshihiro Kameoka
    Shuichi Ota
    Eri Matsuki
    Kazutaka Ozeki
    Takanori Toyama
    Naoki Takahashi
    Takahiro Kumode
    Nobuyuki Aotsuka
    Takuro Yoshimura
    Hideto Tamura
    Ai Omi
    Kazuhiro Shibayama
    Aki Watanabe
    Yasushi Isobe
    Kensuke Kojima
    Jun Takizawa
    Hirokazu Nagai
    Junji Suzumiya
    Sadao Aoki
    International Journal of Hematology, 2025, 121 (2) : 161 - 173
  • [48] Real-world treatment patterns and outcomes of zanubrutinib in chronic lymphocytic leukemia and small lymphocytic leukemia (CLL/SLL)
    Krackeler, Margaret
    Chee, Bryant
    Orchanian, Arthur K.
    Law, Lisa Y.
    Lopez, Alfredo R.
    Buchanan, Susan
    Maglinte, Gregory A.
    Liu, Raymond
    Zhu, Zheng
    Sakoda, Lori C.
    Tavakoli, Jahan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Early Adherence and Persistence to First-Line Ibrutinib or Acalabrutinib Among Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Atrial Fibrillation
    Fradley, Michael
    Lafeuille, Marie-Helene
    Emond, Bruno
    Crawford, Samuel
    Chen, Naijun
    Volodarsky, Raisa
    Nielsen, Jacqueline
    Srivastava, Bhavini Patel
    BLOOD, 2022, 140 : 10983 - 10984
  • [50] Real-World Incidence and Management of Ibrutinib-Induced Hypertension in Patients with Chronic Lymphocytic Leukemia
    Gleaton, Ashley Mariah
    Loop, Matthew Shane
    Coombs, Catherine C.
    Rodgers, Jo E.
    Muluneh, Benyam
    BLOOD, 2022, 140 : 13230 - 13231
12345